首页 › 基金 › FULLER & THALER ASSET MANAGEMENT, INC. › EXEL

FULLER & THALER ASSET MANAGEMENT, INC. 对 EXEL 的持仓历史

EXELIXIS INC · 医疗保健

FULLER & THALER ASSET MANAGEMENT, INC. 在 Q3 2026 的 13F 申报中披露持有 EXEL(EXELIXIS INC)8,795,928 股,市值约 US$513.8M,约占其申报组合的 1.51%,在其申报持仓中市值排名第 2 位。 FULLER & THALER ASSET MANAGEMENT, INC. 最近 13 个申报季度中有 13 个季度披露了 EXEL 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)8.80M 股
申报持仓市值$513.77M
组合权重1.51%
首次申报Q3 2023
最近变动减持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

FULLER & THALER ASSET MANAGEMENT, INC. 对 EXEL 的持仓演变

FULLER & THALER ASSET MANAGEMENT, INC. 于 Q3 2023 首次披露 EXEL 持仓:2,561,487 股(约 US$56.0M)。 该持仓在 Q3 2026 达到峰值 8,795,928 股,市值约 US$513.8M。 在 13 次申报中,FULLER & THALER ASSET MANAGEMENT, INC. 8 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 8,795,928 股、市值约 US$513.8M,环比减持 -133,461 股。。 持仓曾出现大幅变动:Q3 2024 增持约 212% (随后一个季度股价上涨 28%)。

逐季持仓明细

季度股数金额变化
Q3 2023 2.56M $55.97M 新进
Q4 2023 2.62M $62.74M 增持
Q1 2024 2.66M $63.08M 增持
Q2 2024 2.22M $49.93M 减持
Q3 2024 6.92M $179.64M 增持
Q4 2024 7.63M $254.11M 增持
Q1 2025 7.80M $287.79M 增持
Q2 2025 8.78M $386.78M 增持
Q3 2025 8.32M $343.65M 减持
Q4 2025 7.96M $348.93M 减持
Q1 2026 8.54M $366.38M 增持
Q2 2026 8.93M $485.85M 增持
Q3 2026 8.80M $513.77M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 EXEL 与 13F 数据

EXEL(EXELIXIS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 EXEL,申报仓位最大的包括:文艺复兴科技 (US$747.2M), 法拉龙资本管理 (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 EXEL 的基金

查看 EXEL 的全部基金持有人 →

常见问题

How long has FULLER & THALER ASSET MANAGEMENT, INC. held EXEL?

FULLER & THALER ASSET MANAGEMENT, INC. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FULLER & THALER ASSET MANAGEMENT, INC.'s current position in EXEL?

As of Q3 2026, FULLER & THALER ASSET MANAGEMENT, INC. holds 8.80M shares of EXEL (EXELIXIS INC), valued at $513.77M, representing 1.51% of its reported portfolio and ranking #2.

Has FULLER & THALER ASSET MANAGEMENT, INC. been buying or selling EXEL?

In the latest 13F filing (Q3 2026), FULLER & THALER ASSET MANAGEMENT, INC. reduced its position in EXEL. The position peaked in Q3 2026 at 8.80M shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include 文艺复兴科技, 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.